Metabolic

This category holds compounds that sit at the center of metabolic research. Retatrutide is a triple agonist studied at the GLP-1, GIP and glucagon receptors, the most actively researched class of metabolic compounds in the literature since 2022.As with every category, these are research areas. The published work examines receptor pharmacology and metabolic signaling in models, not results in people.For background on incretin receptor biology, read the Retatrutide summary in the Research Library.Where an independent laboratory report exists for a compound, the measurements are published on the COA page, including the compounds we hold no report for.For research use only. Not for human consumption.